Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-877-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Remarks:
- source for read across
- Adequacy of study:
- key study
- Study period:
- From 9 to 23 October, 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 24 June 2002
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Similar Substance 01
- IUPAC Name:
- Similar Substance 01
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands.
- Females: nulliparous and non-pregnant.
- Age at study initiation: 8 - 12 weeks beginning of acclimatization.
- Weight at study initiation: 18.5 g -22.4 g beginning of acclimatization period.
- Housing: in groups of 4 in Makrolon type-3 cages with standard softwood bedding.
- Diet: pelleted standard Kliba 3433, batch no. 57102 mouse maintenance diete, ad libitum.
- Water:community tap water from ltingen, ad libitum.
- Acclimation period: under test conditions after health examination.
- Indication of any skin lesions: only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C.
- Relative humidity: 30 - 70 %
- Air changes: 10 - 15 air changes per hour.
- Photoperiod: 12 hour fluorescent light / 12 hour dark cycle with at least 8 hours music during the light period.
Study design: in vivo (LLNA)
- Vehicle:
- other: ethanol:water, 1:1 (v/v)
- Concentration:
- 2.5, 5 and 10 % (w/v)
- No. of animals per dose:
- three groups of four female
- Details on study design:
- TEST ITEM PREPARATION
- Preparation: the test item was placed into a volumetric flask on a tared Mettler balance and the vehicle (ethanol:water, 1:1 (v/v)) was quantitatively added. The weigh/volume dilutions were prepared individually using a magnetic stirrer as homogenizer.
- Homogeneity: homogeneity in the vehicle was maintained during treatment with the magnetic stirrer.
- Time: the preparations were made shortly before each dosing occasion.
TOPICAL APPLICATION
- Aera of aplication: topical (epidermal) application to the dorsal surface of each ear lobe (left and right).
- Application volume: 25 µl, was spread over the entire dorsal surface (Ø - 8 mm) of each ear lobe once daily for three consecutive days.
- Control: mice treated with an equivalent volume of the relevant vehicle alone.
RADIO-LABELLED
- Administration: 5 days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine).
- Sacrifice: approximately 5 hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group.
- Cell suspension: single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were washed subsequently.
- Incubation: cell suspension was incubated with trichloroacetic acid overnight.
- Proliferative capacity: the proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a β-scintillation counter.
RANGE-FINDING
- Number of animals: 2 mice.
- Test cocnentrations: 1, 2.5, 5 and 10 % (w/v)
- Irritaiton: no irritation effects were observed at the concentrations applied.
- Top dose: the top dose is the highest technically achievable concentration whilst avoiding systemic toxicity and excessive local irritation.
INTERPRETATION OF RAW DATA
The proliferative response of lymph node cells is expressed as the number of radioactive disiniegrations per minute per lymph node (DPM/NODE) and as the ratio of 3HTdR incorporated into lymph node cells of test lymph nodes relative to that recorded for control lymph nodes (STIMULATION INDEX). Before DPM/NODE values were determined, mean scintillation-background DPM was subtracted from test and control raw data.
A test item is regarded as a sensitizer in the LLNA if the following criteria are fulfilled:
- First, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the STIMULATION INDEX.
- Second, that the data is compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
The decision to select a stimulation index of 3 as an arbitrary indication of sensitizing activity was made on the basis of investigations performed with a wide range of chemicals.
OBSERVATIONS
- Mortality / Viability: twice daily from acclimatization start to the termination of in-life phase.
- Body weights: at acclimatization start and prior to necropsy.
- Clinical signs (local/ systemic): daily from acclimatization start to the termination of in-life phase. Especially the treatment sites were recorded carefully.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.7
- Variability:
- No deaths occurred
- Test group / Remarks:
- 10 %
- Parameter:
- SI
- Value:
- 1.5
- Variability:
- No deaths occurred
- Test group / Remarks:
- 5 %
- Parameter:
- SI
- Value:
- 1.8
- Variability:
- No deaths occurred
- Test group / Remarks:
- 2.5 %
- Cellular proliferation data / Observations:
- The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured on a β-scintillation counter. A test item is regarded as a sensitizer if the exposure to at least one concentration resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index.
VIABILITY / MORTALITY
No deaths occurred during the study period
CLINICAL SIGNS
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
BODY WEIGHTS
The body weight of the animals, recorded at the start of acclimatization period and prior to necropsy, was within the range commonly recorded for animals of this strain and age.
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified, according to the CLP Regulation (EC) No 1272/2008
- Conclusions:
- The test item was found to be a non-sensitizer when tested up to 10 % (wlv) in ethanol:water, 1:1 (v/v).
- Executive summary:
In order to study a possible allergenic potential of test substance, three groups of four female mice were each treated with the test item at concentrations of 2.5, 5 and 10 % (w/v) in ethanol:water, 1:1 (v/v) by topical application to the dorsum of each ear lobe (left and right) on three consecutive days. A control group of four mice was treated with the vehicle (ethanol:water, 1:1 (v/v)) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were washed subsequently and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a pscintillation counter.
No test item-related clinical signs were observed. All treated animals survived the scheduled study period.
Stimulation indicies of 1.8, 1.5 and 1.7 were determined with the test item at concentrations of 2.5, 5 and 10 % (w/v) in ethanol:water, 1:1 (v/v). An exact EC3 value could not be calculated because this calculation requires data lying immediately above and below S.l. value of 3.
Conclusion
The test item was found to be a non-sensitizer when tested up to 10 % (wlv) in ethanol:water, 1:1 (v/v).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.